Hudson has previously said he was looking for M&A deals this year to shore up its already-strong position in immunology, ...

Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology ...

MCAS refers to a group of disorders characterized by multisystem symptoms resulting from the accumulation of altered mast cells and/or abnormal mast cell mediator release, causing repeated ...

MCAS refers to a group of disorders characterized by multisystem symptoms resulting from the accumulation of altered mast cells and/or abnormal mast cell mediator release, causing repeated ...

Sanofi S.A. (Paris, France) and Blueprint Medicines Corp. (Blueprint), a U.S.-based, publicly traded biopharmaceutical company specializing in systemic ...

We had previously suggested that a threshold level of mast cell content (tryptase, chymase and so on) exists [15] above which it can provoke coronary artery spasm and/or plaque erosion or rupture.

Abeona Therapeutics' Zevaskyn, a cell therapy based on engineered keratinocytes harvested from patients, has been approved in the US as a treatment for the rare skin disorder recessive dystrophic ...

While there are mental benefits to caffeine, high doses are known to induce anxiety symptoms, and people with panic disorder and social anxiety disorder are especially sensitive. A 2005 study ...

or deep breathing to address the symptoms of throat irritation, cough, and NRV in patients receiving autologous reinfusion of stem cells that have been cryopreserved in DMSO.

Symptoms and treatments depend on the type of heart disease someone has. According to the Centers for Disease Control and Prevention (CDC), heart disease is the leading cause of death in the ...